| 1 |
Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience |
|
| | Yao-Wei Wang, Xin-Hui Wang, Hong-Xia Wang, Ren-Huan Yu | | | World Journal of Clinical Cases. 2023; 11(3): 566 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Case report: Successful outcome of treatment using rituximab in an adult patient with refractory minimal change disease and ß-thalassemia complicating autoimmune hemolytic anemia |
|
| | Jing Zhuang, Zhigang Zhao, Changrong Zhang, Xue Song, Chen Lu, Xuefei Tian, Hong Jiang | | | Frontiers in Medicine. 2022; 9 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease |
|
| | Yan-ni Wang, Zhi-hao Zhang, Hong-jiao Liu, Zhi-yuan Guo, Liang Zou, Ya-mei Zhang, Ying-yong Zhao | | | Acta Pharmacologica Sinica. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting I?B/NF-?B and Keap1/Nrf2 Signaling Pathways |
|
| | Liang-Pu Luo, Ping Suo, Li-Li Ren, Hong-Jiao Liu, Yamei Zhang, Ying-Yong Zhao | | | Frontiers in Pharmacology. 2021; 12 | | | [Pubmed] [Google Scholar] [DOI] | |
|
